Production (Stage)
ProMIS Neurosciences, Inc.
PMN
$0.478
-$0.0028-0.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -99.13% | 68.68% | |||
| Gross Profit | 99.13% | -68.68% | |||
| SG&A Expenses | 209.53% | -197.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 198.12% | -43.57% | |||
| Operating Income | -198.12% | 43.57% | |||
| Income Before Tax | -2,984.76% | -102.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,984.76% | -102.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,984.76% | -102.57% | |||
| EBIT | -198.12% | 43.57% | |||
| EBITDA | -- | 43.62% | |||
| EPS Basic | -3,000.00% | -102.20% | |||
| Normalized Basic EPS | -325.30% | -69.70% | |||
| EPS Diluted | -3,000.00% | -102.20% | |||
| Normalized Diluted EPS | -325.30% | -69.66% | |||
| Average Basic Shares Outstanding | 0.09% | 15.97% | |||
| Average Diluted Shares Outstanding | 0.09% | 15.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||